EVH Stock Analysis: Buy, Sell, or Hold?
EVH - Evolent Health, Inc Class A Common Stock
$4.74
0.04 (0.85%)
â˛
5d:
+1.28%
30d:
+2.16%
90d:
+23.44%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When EVH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: EVH is fairly priced but lacks strong directional signals. At 5.1% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: EVH is fairly priced but lacks strong directional signals. At 5.1% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.99
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$4.96
4.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EVH is currently trading at $4.74, which is considered fair relative to its 30-day fair value range of $3.49 to $5.45. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.1) compared to its historical average (10.5). At these levels, the market is pricing in 5.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, EVH is in a uptrend. The price is approaching resistance at $4.76. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EVH scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.77 (+21.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EVH is in a uptrend. The price is approaching resistance at $4.76. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EVH scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.77 (+21.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.49 -
$5.45
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
49.0%
Protect Your Profits
Holding EVH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (3/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.7% below Wall St target ($5.77)
- NEUTRAL: Trading at premium valuation - market expects 5.1% growth which is achievable
- WARNING: Composite score 34/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.49 -
$5.45
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.86
Resistance Level
$4.76
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.12
Wall Street Target
$5.77
(+21.7%)
Revenue Growth (YoY)
46.9%
Profit Margin
-24.1%
Valuation Premium vs History
+5.1% premium
PE vs Historical
12.1 vs 10.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.1%
(market-implied from PE analysis)
1-Year Target
$4.98
(+5%)
2-Year Target
$5.24
(+11%)
3-Year Target
$5.50
(+16%)
3-Yr Target (if PE normalizes)
(PE: 12â11)
PE COMPRESSION
$4.77
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 95.8%)
$26.48
(+459%)
Base:
(SPY PE: 12.1, Growth: 95.8%)
$16.00
(+238%)
Bear:
(PE: 10.3, Growth: 95.8%)
$13.60
(+187%)
Share & Embed Analysis
Last updated: August 22, 2026 3:40 PM ET
Data refreshes hourly during market hours. Next update: 4:40 PM
Data refreshes hourly during market hours. Next update: 4:40 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EVH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 33 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 37 SELL |
|
BTSG
BrightSpring Health ServâĻ |
STRONG BUY
12 analysts |
$79 | 63 BUY |
Advanced EVH Option Strategies
Professional options setups generated by AI based on today's EVH price and gamma walls.
